US·Regulatory Docket·NRC

Docket No. 50-608

Closed

SHINE Medical Technologies, LLC; Medical Isotope Production Facility

Filed 2026-04-30Last update 2022-07-08

Summary

The U.S. Nuclear Regulatory Commission (NRC) is issuing for public comment draft Supplement 1 to NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, issued October 2015. SHINE Medical Technologies, LLC (SHINE) is requesting a license to operate the Medical Isotope Production Facility (SHINE facility) in Janesville, Wisconsin. The NRC is seeking public comment on this action and has scheduled a public meeting that will take place as an online webinar and teleconference.

Source

Federal Register API

https://www.federalregister.gov/documents/2026/04/30/2026-08415/in-the-matter-of-shine-technologies-llc-shine-medical-isotope-production-facility-direct-and